Call for an instant quote
0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
21 February 2014 09:50
Clinical trials were carried out in vivo as well as in vitro
A new drug which selectively kills dormant cancer cells has been tested by scientists.
The molecule works by inducing dysfunction in mitochondria - the powerhouse of cells.
The research, conducted by Prof Stig Linder of the Swedish Karolinska Instituet and Uppsala University, found that a small molecule named VLX600 has been proven ineffective in killing dormant colon cancer cells in a variety of models, including in clinical trials and in test subjects with
the medical condition.
Experts say that in solid tumours larger than a few millimetres, a lack of oxygen and nutrients is common as a result of insufficient growth in the blood vessels. This can cause cancer cells to remain dormant - and even after they receive treatment, they can divide, causing tumours to grow. This process helps cancers resist radiotherapy and chemotherapy.
The study shows that in these tumour areas that lack oxygen and nutrition, there is a lack of mitochondrial energy production for which the cancer cells cannot compensate. The researchers said: "Our ?ndings suggest that tumour cells in nutritionally compromised microenvironments are sensitive to disturbances of mitochondrial function, resulting in a bioenergetic catastrophe."
The VLX600 molecule was found to cause this dysfunction in mitochondria, causing colon cancer cells to die. When the substance was tested on colon cancer cell lines in vivo, it suppressed tumour growth. The molecule also helped boost other anti-cancer drugs, such as irinotecan.
The study leaders said: "Our ?ndings suggest that tumour cells in metabolically compromised microenvironments have a limited ability to respond to decreased mitochondrial function, and suggest a strategy for targeting the quiescent populations of tumour cells for improved cancer treatment."
People can find more information about travel insurance for cancer patients
22 March 2017
Mountaineers looking to scale the world's highest peak may need to shell out for a GPS device, according to Nepal's tourism chief.
21 March 2017
The effects of being in skyscrapers, at concerts or even walking on wobbly bridges could help scientists understand the experiences of dementia sufferers, researchers are claiming.
18 March 2017
A young actor has released pictures of a lump on her throat that turned out to be thyroid cancer, with hopes the image will raise awareness and alert others who may be suffering from the disease.
17 March 2017
A "promising treatment" for aggressive blood cancer needs more evidence of its effectiveness before NHS doctors will be able to prescribe, a watchdog is warning.
16 March 2017
Millions of Brits are opting for coach holidays over jet-setting and cruises, new research indicates.
15 March 2017
Thousands of flights to and from America's north east have been cancelled in preparation for a "life-threatening" storm poised to hit the country.
14 March 2017
Seniors who experience weight loss should not put it down to the normal ageing process, experts are warning.
11 March 2017
Gatwick Airport is insisting it is still a "credible and deliverable" expansion option, as the airport experienced its busiest ever February.
08 March 2017
Strikes by French air traffic controllers (ATCs) are leading to delays and cancellations across the UK.
10 March 2017
Waiting times for kidney transplant patients have fallen significantly, health officials have said.
09 March 2017
A Dutch snowboarder has been fatally injured in the second avalanche to hit the French Alps in 24 hours.
07 March 2017
The risk of developing a deadly form of breast cancer can be cut by 40% by following a Mediterranean diet, new research has found.